Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells. [electronic resource]
Producer: 20130212Description: 1623-32 p. digitalISSN:- 1475-2662
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Antineoplastic Agents, Phytogenic -- adverse effects
- Caco-2 Cells
- Cell Line, Tumor
- Cell Survival
- Colonic Neoplasms -- immunology
- Dietary Supplements -- adverse effects
- Down-Regulation
- Enterocytes -- cytology
- Humans
- I-kappa B Proteins -- metabolism
- Inflammatory Bowel Diseases -- diet therapy
- Lipopolysaccharides
- NF-kappa B -- antagonists & inhibitors
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type II -- genetics
- Phosphorylation
- Protein Processing, Post-Translational
- Proteolysis
- RNA, Messenger -- metabolism
- Resveratrol
- Stilbenes -- adverse effects
- Toll-Like Receptor 4 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.